Rosanne Catalano

Title: Rosanne Catalano: Innovator in Amyloid-Associated Disorders

Introduction

Rosanne Catalano is a notable inventor based in Hayward, California. She has made significant contributions to the field of biomedical research, particularly in the prevention and treatment of amyloid-associated disorders. Her innovative work has led to the development of a patent that addresses critical aspects of microglial cell activation.

Latest Patents

Rosanne Catalano holds a patent for the "Prevention and treatment of amyloid-associated disorders." This invention provides assays to identify compounds that affect microglial cell activation. Specifically, it includes assays to identify compounds that influence the secretion of cytokines from microglial cells by modulating PGE-mediated activity. The assays involve testing microglial cell activation by contacting microglia with compounds that modulate β-amyloid PGE-mediated activation. The effectiveness of candidate compounds can be determined by comparing their effects with a control culture or a standardized profile.

Career Highlights

Throughout her career, Rosanne has focused on advancing the understanding of amyloid-associated disorders. Her research has contributed to the development of therapeutic strategies aimed at mitigating the effects of these conditions. With one patent to her name, she has established herself as a key figure in her field.

Collaborations

Rosanne has collaborated with notable colleagues, including Paul Andrew Hyslop and Foy Dean Miller. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the area of amyloid-associated disorders.

Conclusion

Rosanne Catalano's innovative work in the field of amyloid-associated disorders exemplifies her commitment to advancing biomedical research. Her patent reflects her dedication to finding solutions for complex health issues.